Global Non-invasive Vaccine Market Growth 2022-2028
Noninvasive vaccine delivery systems need to incorporate an effective adjuvant, specially designed for triggering both mucosal and systemic immune responses.
The global market for Non-invasive Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Non-invasive Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Non-invasive Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Non-invasive Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Non-invasive Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Non-invasive Vaccine players cover Merck, GSK, Sanofi, Lanzhou Institute and Serum Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Non-invasive Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Non-invasive Vaccine market, with both quantitative and qualitative data, to help readers understand how the Non-invasive Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Non-invasive Vaccine market and forecasts the market size by Type (Oral Vaccine and Nasal Spray Vaccine,), by Application (Public and Private.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Oral Vaccine
Nasal Spray Vaccine
Segmentation by application
Public
Private
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
AstraZeneca
Cipla
BCHT
Chapter Introduction
Chapter 1: Scope of Non-invasive Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Non-invasive Vaccine market size (sales and revenue) and CAGR, Non-invasive Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Non-invasive Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Non-invasive Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Non-invasive Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-invasive Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non-invasive Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non-invasive Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Non-invasive Vaccine Segment by Type
2.2.1 Oral Vaccine
2.2.2 Nasal Spray Vaccine
2.3 Non-invasive Vaccine Sales by Type
2.3.1 Global Non-invasive Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Non-invasive Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non-invasive Vaccine Sale Price by Type (2017-2022)
2.4 Non-invasive Vaccine Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Non-invasive Vaccine Sales by Application
2.5.1 Global Non-invasive Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Non-invasive Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non-invasive Vaccine Sale Price by Application (2017-2022)
3 Global Non-invasive Vaccine by Company
3.1 Global Non-invasive Vaccine Breakdown Data by Company
3.1.1 Global Non-invasive Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Non-invasive Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Non-invasive Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Non-invasive Vaccine Revenue by Company (2020-2022)
3.2.2 Global Non-invasive Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Non-invasive Vaccine Sale Price by Company
3.4 Key Manufacturers Non-invasive Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Vaccine Product Location Distribution
3.4.2 Players Non-invasive Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-invasive Vaccine by Geographic Region
4.1 World Historic Non-invasive Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Non-invasive Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non-invasive Vaccine Annual Revenue by Geographic Region
4.2 World Historic Non-invasive Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Non-invasive Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non-invasive Vaccine Annual Revenue by Country/Region
4.3 Americas Non-invasive Vaccine Sales Growth
4.4 APAC Non-invasive Vaccine Sales Growth
4.5 Europe Non-invasive Vaccine Sales Growth
4.6 Middle East & Africa Non-invasive Vaccine Sales Growth
5 Americas
5.1 Americas Non-invasive Vaccine Sales by Country
5.1.1 Americas Non-invasive Vaccine Sales by Country (2017-2022)
5.1.2 Americas Non-invasive Vaccine Revenue by Country (2017-2022)
5.2 Americas Non-invasive Vaccine Sales by Type
5.3 Americas Non-invasive Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Vaccine Sales by Region
6.1.1 APAC Non-invasive Vaccine Sales by Region (2017-2022)
6.1.2 APAC Non-invasive Vaccine Revenue by Region (2017-2022)
6.2 APAC Non-invasive Vaccine Sales by Type
6.3 APAC Non-invasive Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-invasive Vaccine by Country
7.1.1 Europe Non-invasive Vaccine Sales by Country (2017-2022)
7.1.2 Europe Non-invasive Vaccine Revenue by Country (2017-2022)
7.2 Europe Non-invasive Vaccine Sales by Type
7.3 Europe Non-invasive Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-invasive Vaccine by Country
8.1.1 Middle East & Africa Non-invasive Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non-invasive Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Non-invasive Vaccine Sales by Type
8.3 Middle East & Africa Non-invasive Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Vaccine
10.3 Manufacturing Process Analysis of Non-invasive Vaccine
10.4 Industry Chain Structure of Non-invasive Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Vaccine Distributors
11.3 Non-invasive Vaccine Customer
12 World Forecast Review for Non-invasive Vaccine by Geographic Region
12.1 Global Non-invasive Vaccine Market Size Forecast by Region
12.1.1 Global Non-invasive Vaccine Forecast by Region (2023-2028)
12.1.2 Global Non-invasive Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-invasive Vaccine Forecast by Type
12.7 Global Non-invasive Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Non-invasive Vaccine Product Offered
13.1.3 Merck Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Non-invasive Vaccine Product Offered
13.2.3 GSK Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Non-invasive Vaccine Product Offered
13.3.3 Sanofi Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Non-invasive Vaccine Product Offered
13.4.3 Lanzhou Institute Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Non-invasive Vaccine Product Offered
13.5.3 Serum Institute Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Non-invasive Vaccine Product Offered
13.6.3 Valneva Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Non-invasive Vaccine Product Offered
13.7.3 Shanghai United Cell Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Non-invasive Vaccine Product Offered
13.8.3 Bibcol Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Non-invasive Vaccine Product Offered
13.9.3 PaxVax Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Non-invasive Vaccine Product Offered
13.10.3 Vabiotech Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Non-invasive Vaccine Product Offered
13.11.3 Tiantan Biological Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Non-invasive Vaccine Product Offered
13.12.3 EuBiologics Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Non-invasive Vaccine Product Offered
13.13.3 Panacea Biotec Ltd Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Non-invasive Vaccine Product Offered
13.14.3 Bio-Med Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Non-invasive Vaccine Product Offered
13.15.3 Halfkin Bio-Pharmaceuticals Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
13.16 AstraZeneca
13.16.1 AstraZeneca Company Information
13.16.2 AstraZeneca Non-invasive Vaccine Product Offered
13.16.3 AstraZeneca Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 AstraZeneca Main Business Overview
13.16.5 AstraZeneca Latest Developments
13.17 Cipla
13.17.1 Cipla Company Information
13.17.2 Cipla Non-invasive Vaccine Product Offered
13.17.3 Cipla Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Cipla Main Business Overview
13.17.5 Cipla Latest Developments
13.18 BCHT
13.18.1 BCHT Company Information
13.18.2 BCHT Non-invasive Vaccine Product Offered
13.18.3 BCHT Non-invasive Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 BCHT Main Business Overview
13.18.5 BCHT Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Non-invasive Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non-invasive Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Vaccine
Table 4. Major Players of Nasal Spray Vaccine
Table 5. Global Non-invasive Vaccine Sales by Type (2017-2022) & (Units)
Table 6. Global Non-invasive Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Non-invasive Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Non-invasive Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Non-invasive Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Non-invasive Vaccine Sales by Application (2017-2022) & (Units)
Table 11. Global Non-invasive Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Non-invasive Vaccine Revenue by Application (2017-2022)
Table 13. Global Non-invasive Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Non-invasive Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Non-invasive Vaccine Sales by Company (2020-2022) & (Units)
Table 16. Global Non-invasive Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Non-invasive Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Non-invasive Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Non-invasive Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Non-invasive Vaccine Producing Area Distribution and Sales Area
Table 21. Players Non-invasive Vaccine Products Offered
Table 22. Non-invasive Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-invasive Vaccine Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Non-invasive Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Non-invasive Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Non-invasive Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Non-invasive Vaccine Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Non-invasive Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Non-invasive Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Non-invasive Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Non-invasive Vaccine Sales by Country (2017-2022) & (Units)
Table 34. Americas Non-invasive Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Non-invasive Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Non-invasive Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Non-invasive Vaccine Sales by Type (2017-2022) & (Units)
Table 38. Americas Non-invasive Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Non-invasive Vaccine Sales by Application (2017-2022) & (Units)
Table 40. Americas Non-invasive Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Non-invasive Vaccine Sales by Region (2017-2022) & (Units)
Table 42. APAC Non-invasive Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Non-invasive Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Non-invasive Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Non-invasive Vaccine Sales by Type (2017-2022) & (Units)
Table 46. APAC Non-invasive Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Non-invasive Vaccine Sales by Application (2017-2022) & (Units)
Table 48. APAC Non-invasive Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Non-invasive Vaccine Sales by Country (2017-2022) & (Units)
Table 50. Europe Non-invasive Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Non-invasive Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Non-invasive Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Non-invasive Vaccine Sales by Type (2017-2022) & (Units)
Table 54. Europe Non-invasive Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Non-invasive Vaccine Sales by Application (2017-2022) & (Units)
Table 56. Europe Non-invasive Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Non-invasive Vaccine Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Non-invasive Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Non-invasive Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Non-invasive Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Non-invasive Vaccine Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Non-invasive Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Non-invasive Vaccine Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Non-invasive Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Non-invasive Vaccine
Table 66. Key Market Challenges & Risks of Non-invasive Vaccine
Table 67. Key Industry Trends of Non-invasive Vaccine
Table 68. Non-invasive Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Non-invasive Vaccine Distributors List
Table 71. Non-invasive Vaccine Customer List
Table 72. Global Non-invasive Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Non-invasive Vaccine Sales Market Forecast by Region
Table 74. Global Non-invasive Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Non-invasive Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Non-invasive Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Non-invasive Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Non-invasive Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Non-invasive Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Non-invasive Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Non-invasive Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Non-invasive Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Non-invasive Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Non-invasive Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Non-invasive Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Non-invasive Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Non-invasive Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Non-invasive Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Non-invasive Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Non-invasive Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Non-invasive Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Non-invasive Vaccine Product Offered
Table 94. Merck Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. GSK Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Non-invasive Vaccine Product Offered
Table 99. GSK Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Sanofi Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Non-invasive Vaccine Product Offered
Table 104. Sanofi Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Lanzhou Institute Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Lanzhou Institute Non-invasive Vaccine Product Offered
Table 109. Lanzhou Institute Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lanzhou Institute Main Business
Table 111. Lanzhou Institute Latest Developments
Table 112. Serum Institute Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Serum Institute Non-invasive Vaccine Product Offered
Table 114. Serum Institute Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Serum Institute Main Business
Table 116. Serum Institute Latest Developments
Table 117. Valneva Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Valneva Non-invasive Vaccine Product Offered
Table 119. Valneva Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Valneva Main Business
Table 121. Valneva Latest Developments
Table 122. Shanghai United Cell Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai United Cell Non-invasive Vaccine Product Offered
Table 124. Shanghai United Cell Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Shanghai United Cell Main Business
Table 126. Shanghai United Cell Latest Developments
Table 127. Bibcol Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Bibcol Non-invasive Vaccine Product Offered
Table 129. Bibcol Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Bibcol Main Business
Table 131. Bibcol Latest Developments
Table 132. PaxVax Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. PaxVax Non-invasive Vaccine Product Offered
Table 134. PaxVax Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. PaxVax Main Business
Table 136. PaxVax Latest Developments
Table 137. Vabiotech Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Vabiotech Non-invasive Vaccine Product Offered
Table 139. Vabiotech Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Vabiotech Main Business
Table 141. Vabiotech Latest Developments
Table 142. Tiantan Biological Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Tiantan Biological Non-invasive Vaccine Product Offered
Table 144. Tiantan Biological Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Tiantan Biological Main Business
Table 146. Tiantan Biological Latest Developments
Table 147. EuBiologics Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. EuBiologics Non-invasive Vaccine Product Offered
Table 149. EuBiologics Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. EuBiologics Main Business
Table 151. EuBiologics Latest Developments
Table 152. Panacea Biotec Ltd Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Panacea Biotec Ltd Non-invasive Vaccine Product Offered
Table 154. Panacea Biotec Ltd Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Panacea Biotec Ltd Main Business
Table 156. Panacea Biotec Ltd Latest Developments
Table 157. Bio-Med Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Bio-Med Non-invasive Vaccine Product Offered
Table 159. Bio-Med Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Bio-Med Main Business
Table 161. Bio-Med Latest Developments
Table 162. Halfkin Bio-Pharmaceuticals Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. Halfkin Bio-Pharmaceuticals Non-invasive Vaccine Product Offered
Table 164. Halfkin Bio-Pharmaceuticals Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Halfkin Bio-Pharmaceuticals Main Business
Table 166. Halfkin Bio-Pharmaceuticals Latest Developments
Table 167. AstraZeneca Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. AstraZeneca Non-invasive Vaccine Product Offered
Table 169. AstraZeneca Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. AstraZeneca Main Business
Table 171. AstraZeneca Latest Developments
Table 172. Cipla Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Cipla Non-invasive Vaccine Product Offered
Table 174. Cipla Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Cipla Main Business
Table 176. Cipla Latest Developments
Table 177. BCHT Basic Information, Non-invasive Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 178. BCHT Non-invasive Vaccine Product Offered
Table 179. BCHT Non-invasive Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. BCHT Main Business
Table 181. BCHT Latest Developments
List of Figures
Figure 1. Picture of Non-invasive Vaccine
Figure 2. Non-invasive Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Vaccine Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Non-invasive Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non-invasive Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Vaccine
Figure 10. Product Picture of Nasal Spray Vaccine
Figure 11. Global Non-invasive Vaccine Sales Market Share by Type in 2021
Figure 12. Global Non-invasive Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Non-invasive Vaccine Consumed in Public
Figure 14. Global Non-invasive Vaccine Market: Public (2017-2022) & (Units)
Figure 15. Non-invasive Vaccine Consumed in Private
Figure 16. Global Non-invasive Vaccine Market: Private (2017-2022) & (Units)
Figure 17. Global Non-invasive Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Non-invasive Vaccine Revenue Market Share by Application in 2021
Figure 19. Non-invasive Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Non-invasive Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Non-invasive Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Non-invasive Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Non-invasive Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Non-invasive Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Non-invasive Vaccine Sales 2017-2022 (Units)
Figure 26. Americas Non-invasive Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Non-invasive Vaccine Sales 2017-2022 (Units)
Figure 28. APAC Non-invasive Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Non-invasive Vaccine Sales 2017-2022 (Units)
Figure 30. Europe Non-invasive Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Non-invasive Vaccine Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Non-invasive Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Non-invasive Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Non-invasive Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Non-invasive Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Non-invasive Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Non-invasive Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Non-invasive Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Non-invasive Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Non-invasive Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Non-invasive Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Non-invasive Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Non-invasive Vaccine
Figure 63. Industry Chain Structure of Non-invasive Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets